Zanamivir [139110-80-8]
Cat# T2529-100mg
Size : 100mg
Brand : TargetMol
Zanamivir
Zanamivir (GG167) is a guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
Catalog No. T2529Cas No. 139110-80-8
Purity:99.98%
Contact us for more batch information
Resource Download
COA HNMR HPLC
Zanamivir
Catalog No. T2529Cas No. 139110-80-8
Zanamivir (GG167) is a guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose. Pack Size | |
---|---|
5 mg | |
10 mg | |
25 mg | |
50 mg | |
100 mg | |
200 mg | |
1 mL x 10 mM (in DMSO) |
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
Description | Zanamivir (GG167) is a guanido-neuraminic acid that is used to inhibit NEURAMINIDASE. |
Targets&IC50 | Influenza B:2.7 nM, Influenza A:0.95 nM |
In vitro | Zanamivir reduces pulmonary viral titers and decreases morbidity and mortality rates in a lethal murine model infected with the virus. |
In vivo | Zanamivir effectively reduces viral replication in vitro by inhibiting the influenza neuraminidase and preventing the cleavage of sialic acid residues. This interference blocks the spread of progeny viruses in mucosal secretions and lowers viral infectivity. Furthermore, Zanamivir diminishes the area of plaques formed by neuraminidase-deficient mutants, indicating that its action in disrupting cell-cell fusion is independent of its neuraminidase inhibition activity. The compound also prevents the adhesion and fusion of persistently infected cells with uninfected erythrocytes. Assessment through lipid mixing and content mixing reveals that Zanamivir does not affect erythrocyte adhesion but does inhibit HA2b-red blood cell fusion. Additionally, Zanamivir leads to decreased sensitivity in influenza A/H1N1 variants His274Asn, His274 gly, His274Ser, and His274 gln. |
Alias | GG167 |
Molecular Weight | 332.31 |
Formula | C12H20N4O7 |
Cas No. | 139110-80-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | H2O: 10 mg/mL (30.09 mM), Sonication and heating are recommended. DMSO: <1 mg/mL (Insoluble) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
H2O
|
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
GG 167inhibitZanamivirInhibitorGG-167Influenza VirusAntibiotic
Related Tags: buy Zanamivir | purchase Zanamivir | Zanamivir cost | order Zanamivir | Zanamivir chemical structure | Zanamivir in vivo | Zanamivir in vitro | Zanamivir formula | Zanamivir molecular weight